Review



hepg2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC hepg2
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in <t>HepG2</t> and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 29980 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/pmc13091082-51-0-1
    Average 99 stars, based on 29980 article reviews
    hepg2 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "Elevated diurnal CD36 expression disrupts the bile acid synthesis rhythm leading to cholestatic liver injury and inflammation via the HMGCR/CYP7A1 axis"

    Article Title: Elevated diurnal CD36 expression disrupts the bile acid synthesis rhythm leading to cholestatic liver injury and inflammation via the HMGCR/CYP7A1 axis

    Journal: Genes & Diseases

    doi: 10.1016/j.gendis.2025.101776

    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Figure Legend Snippet: Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.

    Techniques Used: Expressing, Immunohistochemistry, Staining, Western Blot, Quantitative Proteomics, Double Immunofluorescence Staining, Reverse Transcription, Cell Culture, Control, Ligation

    Related Articles

    CCK-8 Assay:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Cell Counting:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Cell Culture:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Single Cell Gel Electrophoresis:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Incubation:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Isolation:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D

    Purification:

    Article Title: Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
    Article Snippet: humidified incubator containing 5% CO 2 and utilized for all subsequent experiments. Human embryonic kidney cells (HEK293T, CRL-3216) and human hepatoblastoma cells (HepG2, HB-8065), obtained from the American Type Culture Collection, were used as cell line controls. Cell proliferation and viability were assessed at various time points after seeding oUSCs, yUSCs, HEK293 cells, and HepG2 cells on 3D



    Similar Products

    hepg2  (ATCC)
    99
    ATCC hepg2
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in <t>HepG2</t> and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/pmc13091082-51-0-1
    Average 99 stars, based on 1 article reviews
    hepg2 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC hepg2 cells
    The effects of SERBP1 depletion on PPARγ target genes in <t>HepG2</t> cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.
    Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/pmc13264020-398-9-14
    Average 99 stars, based on 1 article reviews
    hepg2 cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC human hepg2 hepatocarcinoma cells
    The effects of SERBP1 depletion on PPARγ target genes in <t>HepG2</t> cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.
    Human Hepg2 Hepatocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/pm42320200-374-0-4
    Average 99 stars, based on 1 article reviews
    human hepg2 hepatocarcinoma cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC hep g2 cells
    The effects of SERBP1 depletion on PPARγ target genes in <t>HepG2</t> cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.
    Hep G2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/us12655206-413-52-71
    Average 99 stars, based on 1 article reviews
    hep g2 cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC mouse mammary tumor
    The effects of SERBP1 depletion on PPARγ target genes in <t>HepG2</t> cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.
    Mouse Mammary Tumor, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hep+g2/Hep+G2/us12655447-998-166-171
    Average 99 stars, based on 1 article reviews
    mouse mammary tumor - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.

    Journal: Genes & Diseases

    Article Title: Elevated diurnal CD36 expression disrupts the bile acid synthesis rhythm leading to cholestatic liver injury and inflammation via the HMGCR/CYP7A1 axis

    doi: 10.1016/j.gendis.2025.101776

    Figure Lengend Snippet: Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.

    Article Snippet: HepG2 (ATCC, USA) and AML12 cells were cultured in Dulbecco's modified Eagle medium (HyClone, USA) supplemented with 10% fetal bovine serum and 100 U/mL penicillin‒streptomycin at 37 °C in a humidified incubator containing 5% CO 2 .

    Techniques: Expressing, Immunohistochemistry, Staining, Western Blot, Quantitative Proteomics, Double Immunofluorescence Staining, Reverse Transcription, Cell Culture, Control, Ligation

    The effects of SERBP1 depletion on PPARγ target genes in HepG2 cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.

    Journal: iScience

    Article Title: NEK2A regulates PLIN2 expression through a SERBP1 dependent pathway

    doi: 10.1016/j.isci.2026.116254

    Figure Lengend Snippet: The effects of SERBP1 depletion on PPARγ target genes in HepG2 cells HepG2 cells were treated with scrambled short hairpin RNA (sh Scr) or shRNA against SERBP1 (sh SERBP ). The cells were incubated with or without 0.5 mM oleic acid (OA). Total RNA was isolated, and RT-PCR was performed to determine the mRNA levels of SERBP1 (A), PLIN2 (B), PLIN3 (C), and CD36 (D), normalized to GAPDH . The expression level in OA-treated sh Scr was set to 1.0. The results are shown as scattered dot plots (mean ± SD). ∗∗ p < 0.01, one-way ANOVA followed by Tukey-Kramer post hoc test.

    Article Snippet: HuH7 cells were obtained from JCRB Cell Bank, and HepG2 cells were obtained from ATCC.

    Techniques: shRNA, Incubation, Isolation, Reverse Transcription Polymerase Chain Reaction, Expressing